Oculos Development Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oculos Development Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oculos Development Services Today - Breaking & Trending Today

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis

Published: March 29, 2022

Ocuphire Announces Positive Topline Results from MIRA-3 Phase 3 FDA Registration Trial for Nyxol® in the Reversal of Mydriasis - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com

Related Topics:

Corey DavisOcuphire PharmaIuvo BioscienceMina SoochNyxol Development PlanOculos Development ServicesOcuphire Pharma IncMeets Primary Endpoint WithSubjects ReturningBaseline Pupil DiameterPlacebo SubjectsTrial Showing Substantial BenefitAccelerating ReversalOnly Dilation Reversal DropWebcast TodayDevelopment PlanNext StepsMydriasis MarketPrivate Securities Litigation Reform ActCuphire Announces Positive Topline Results From Mira 3 Phase Fda Registration Trial For Nyxol In The Reversal Of Mydriasis